Journal profile · Immunology
European Journal of Immunology
ISSN 0014-2980 · eISSN 1521-4141 · Wiley-VCH Verlag · UNITED STATES · Monthly · Founded 1971
European Journal of Immunology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.08; hybrid open access; APC about USD 4,550; median 167 days to acceptance (86 articles, last 24 months); community-reported acceptance: fairly hard; 261 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European Journal of Immunology is published by Wiley-VCH Verlag and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are T-cell and B-cell Immunology, Immune Cell Function and Interaction and Immunotherapy and Immune Responses, together about 57.2% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
EJI is an immunology research journal, focusing on various aspects of immunology including, but not limited to: Basic: Adaptive immunity, Innate immunity, Leukocyte and lymphoid organ ontogeny, Molecular immunology and signaling, New technology, Tissue immunology and leukocyte trafficking Basic/Clinical studies*: Allergy and inflammation, Immunity to infection, Immunodeficiencies and autoimmunity, Transplantation and tolerance, Immunomodulation and Immune Therapies, Tumor immunology *Clinical studies EJI's editorial team understands the experimental restrictions of clinical/human studies. EJI considers descriptive clinical papers without a mechanism, provided that the studies are hypothesis-driven with a clear rationale and informative results that forward our understanding of immunological processes and disease.
Source: LetPub
Research area (LetPub): Immunology
Main research topics OpenAlex counts of recent articles; shares are approximate
- T-cell and B-cell ImmunologyImmunology and Microbiology23%
- Immune Cell Function and InteractionImmunology and Microbiology21.4%
- Immunotherapy and Immune ResponsesImmunology and Microbiology12.8%
- Monoclonal and Polyclonal Antibodies ResearchMedicine8.4%
- Immune Response and InflammationImmunology and Microbiology6.4%
- Cell Adhesion Molecules ResearchMedicine3%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology2.6%
- CAR-T cell therapy researchMedicine2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.08LetPub ·
- CiteScore 2026-06
- 6.5LetPub ·
- SJR 2026-06
- 1.67LetPub ·
- SNIP 2026-06
- 0.86LetPub ·
- h-index
- 187LetPub ·
- h-index
- 298OpenAlex ·
- i10-index
- 14,205OpenAlex ·
- 2-year mean citedness
- 3.55OpenAlex ·
- Self-citation rate
- 2.4%LetPub ·
- Share of gold OA articles
- 65.19%LetPub ·
Volume
- Articles per year
- 198LetPub ·
Articles by year OpenAlex count · 20,774 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 181 | 145 | 77 |
| 2025 | 261 | 221 | 785 |
| 2024 | 258 | 229 | 1,626 |
| 2023 | 301 | 281 | 2,986 |
| 2022 | 258 | 170 | 2,894 |
| 2021 | 332 | 258 | 6,022 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
167 daysMedian, submission to acceptance · P25–P75 112 days – 218 days
- Acceptance to online
- median 20 days (86 articles)
- Submission to online
- median 194 days
- Sample
- 86 articles with submission and acceptance dates (472 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,550 / EUR 3,920 / GBP 3,250 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley-VCH Verlag
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1971
- ISSN
- 0014-2980
- Electronic ISSN
- 1521-4141
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about European Journal of Immunology
What CAS zone is European Journal of Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Immunology is in Zone 3 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Immunology?
The latest impact factor listed by LetPub is 4.08; CiteScore 6.5, h-index 298.
How long does peer review take at European Journal of Immunology?
Based on the dates recorded on 86 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 167 days (interquartile range 112–218 days); authors report an average review time of about 1 month; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index European Journal of Immunology?
According to LetPub and DOAJ records, European Journal of Immunology is indexed in SCIE and Scopus.
Is European Journal of Immunology open access, and what is the APC?
European Journal of Immunology is a hybrid journal. For open-access publication: APC about USD 4,550.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .